CD4 and irritable bowel syndrome: Takahara et al. explored BBR for IBD from multiple perspectives, showing that BBR might have an impact on the immune system and regulate CD4+ T cells, especially LP CD4+ T cells isolated from colitis SCID mice in vitro.